Application no. and date | 14714586.6 (espacenet) (Federated) (European Patent Register), 20140317 | Patent/reg. no. and date | DK/EP 2976360, 20191127 | Publication date | 20160127 | Priority no. and date | WO PCT/EP2013/000817, 20130318 | EP pub. no. and date |
EP 2976360 20160127 | Effective date | | Applicant/owner | TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH, Freiligrathstrasse 12
55131 Mainz, DE, Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-Chome Chuo-ku Tokyo 103-8411 , JP | Applicant ref. no. | V1912-044-DK | Inventor | TÜRECI, Özlem, Philipp-von-Zabern-Platz 1
55116 Mainz, DE, SAHIN, Ugur, Philipp-von-Zabern-Platz 1
55116 Mainz, DE | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) | Title | TERAPI, HVORI DER ER INVOLVERET ANTISTOFFER MOD CLAUDIN 18.2, TIL BEHANDLING AF CANCER | Int. application no. | EP2014000719 | Int. publication no. | WO2014146778 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|